BUDGET IMPACT ANALYSIS OF NIRAPARIB AND OLAPARUB AS MAINTENANCE THERAPY FOR PLATINUM SENSITIVE, RECURRENT OVARIAN CANCER IN THE US

被引：0
|
作者：
Wu, L. [1 ]
Zhong, L. [1 ]
机构：
[1] Texas A&M Univ, College Stn, TX USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.132
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN54
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of maintenance niraparib with an individualized starting dosage in patients with platinum-sensitive recurrent ovarian cancer in China
    Shi, Yin
    Xiao, Di
    Li, Shuishi
    Liu, Shao
    Zhang, Yu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Maintenance therapy utilization in platinum-sensitive recurrent epithelial ovarian cancer: A 'real-world' analysis
    Moss, H. A.
    Havrilesky, L. J.
    Kauff, N. D.
    Secord, A. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 204 - 204
  • [23] Decision analysis for secondline maintenance treatment of platinum sensitive recurrent ovarian cancer: a review
    Arend, Rebecca
    Westin, Shannon Neville
    Coleman, Robert L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (05) : 684 - 694
  • [24] Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Guerra Alia, Eva Maria
    Sempere Ortega, Cayetano
    Cortes Salgado, Alfonso
    Sanchez Martinez, Concepcion
    Galindo Alvarez, Julio
    Perez Miez, Belen
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 447 - 455
  • [25] EFFICACY AND SAFETY OF NIRAPARIB MAINTENANCE TREATMENT IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER AFTER SHORTER OR LONGER CHEMOTHERAPY: A POST HOC SUBGROUP ANALYSIS
    Gao, Y.
    Wu, X.
    Zhu, J.
    Yin, R.
    Yang, J.
    Liu, J.
    Wang, J.
    Wu, L.
    Liu, Z.
    Wang, D.
    Lou, G.
    Yang, H.
    Zhou, Q.
    Kong, B.
    Huang, Y.
    Chen, L.
    Li, G.
    An, R.
    Tan, T.
    Dong, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A10 - A11
  • [26] Efficacy of Niraparib Maintenance Therapy in Chinese Women With Platinum-Sensitive Recurrent Ovarian Cancer With and Without Secondary Cytoreductive Surgery: Results From the NORA Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 17 - 18
  • [27] PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis
    Smith, Haller J.
    Haygood, Christen L. Walters
    Arend, Rebecca C.
    Leath, Charles A., III
    Straughn, Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 59 - 62
  • [28] A cost-effectiveness analysis of three PARP inhibitors for maintenance therapy in platinum-sensitive recurrent ovarian cancer
    Liu, A. Y.
    Cohen, J. G.
    Walsh, C.
    Holschneider, C. H.
    Sinno, A. K.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 9 - 9
  • [29] A Cost-Effectiveness Analysis of Three PARP Inhibitors for Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer
    Liu, A. Y.
    Cohen, J. G.
    Walsh, C. S.
    Holschneider, C. H.
    Sinno, A. K.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 196 - 196
  • [30] THE IMPACT OF PREVIOUS MAINTENANCE THERAPY ON DISEASE PRESENTATION AND SECONDARY CYTOREDUCTIVE PERIOPERATIVE OUTCOMES IN PLATINUM SENSITIVE OVARIAN CANCER RECURRENT PATIENTS
    Loverro, Matteo
    Capomacchia, Filippo Maria
    Marchetti, Claudia
    Conte, Carmine
    Faustini, Alice Zampolini
    Ferrante, Maria Giulia
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A283 - A283
12345